1. Home
  2. Analysis
  3. Focal-segmental-glomerulosclerosis

Focal segmental glomerulosclerosis: treatments, associated drugs and conditions

Summary:

Focal segmental glomerulosclerosis: scar tissue that forms in parts of the kidney called glomeruli.

We study 2,786 people who have Focal segmental glomerulosclerosis. The information that eHealthMe analyzes includes:

- Medications that treat Focal segmental glomerulosclerosis and their effectiveness
- 176 drugs that are associated with Focal segmental glomerulosclerosis


Number of reports submitted per year:

Focal segmental glomerulosclerosis: 2,786 reports.

All the drugs that are associated with Focal segmental glomerulosclerosis:

Do you take any medication?

- You can use our AI-powered tools to monitor drug safety and effectiveness.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all conditions on eHealthMe.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.